Cyclosporin A Therapy in Childhood Nephrotic Syndrome
NCT03219684 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2017-07-17
Summary
Nephrotic syndrome (NS) is among the most common pediatric kidney diseases and is defined as massive proteinuria (\>40 mg/m2/h or urine protein to creatinine ratio \>2 g/g) leading to hypoalbuminemia (\<2.5 g/dL), edema, and hyperlipidemia. 60-70 % of patients present prior to age of 6 years
Conditions
- Steroid Dependent and Steroid Resistent Nephrotic Syndrome
Interventions
- DIAGNOSTIC_TEST
-
serum protein ,kidney function ,liver function.,serum cholesterol
monthly review of serum protein kidney function ,liver function and serum cholesterol in all patients
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 1 Year
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-04-01
- Primary Completion
- 2019-04-01
- Completion
- 2019-08-01
More Related Trials
-
Losartan and Uric Acid Metabolism in Children With Proteinuric Nephropathies
NCT05402397 ·Status: COMPLETED ·Phase: PHASE4
-
Glucocorticoid in Treatment of Adult Idiopathic Nephrotic Syndrome:a Prospective Observational Study
NCT02298335 ·Status: COMPLETED ·Phase: NA
-
Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant
NCT01491919 ·Status: COMPLETED ·Phase: PHASE1
-
Finerenone Therapy for Pediatric HSPN With Mild Proteinuria
NCT07315191 ·Status: RECRUITING ·Phase: PHASE4
-
Efficacy and Safety of Dapagliflozin in Children With Proteinuric Chronic Kidney Disease
NCT04531397 ·Status: WITHDRAWN ·Phase: PHASE4
-
Colchicine for Diabetic Nephropathy
NCT01005121 ·Status: UNKNOWN ·Phase: PHASE2
-
Urinary Biomarkers of the Progression of Alport Kidney Disease
NCT01705132 ·Status: COMPLETED
-
Trial of Angiotensin Converting Enzyme Inhibition in Infants With Single Ventricle--Pediatric Heart Network
NCT00113087 ·Status: COMPLETED ·Phase: PHASE3
-
Experience With H.P. Acthar Gel Treatment of Patients With Nephrotic Syndrome/Proteinuria Due to Various Etiologies and Its Effect on Podocyte Function
NCT03644771 ·Status: UNKNOWN
-
Ciclosporin A Preconditioning for Renal Artery Stenosis
NCT03382301 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Strict Blood Pressure Control and ACE-Inhibition on Progression of Chronic Renal Failure in Pediatric Patients
NCT00221845 ·Status: COMPLETED ·Phase: PHASE3
-
The Comparative Effectiveness of Alprostadil,Sodium Ferulate and Dopamine in Pediatric Acute Kidney Injury
NCT03892447 ·Status: UNKNOWN ·Phase: PHASE4
-
Trial of Pulse Steroid Therapy in Kawasaki Disease--Pediatric Heart Network
NCT00132080 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Two Year of RAAS Alone or in Combination With Spironolactone Therapy
NCT03502031 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety and Efficacy of ACEI in Alport Syndrome Patients With COL4A3/COL4A4/COL4A5 Variants
NCT05133050 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Spironolactone in CKD Enabled by Chlorthalidone: PILOT
NCT05222191 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy and Safety Study of Second-Line Treatment for Hypertension With Autosomal Dominant Polycystic Kidney Disease(ADPKD)
NCT00890279 ·Status: UNKNOWN ·Phase: PHASE2
-
Multi-center Controlled Clinical Trials in Alport Syndrome-A Feasibility Study
NCT01696253 ·Status: COMPLETED
-
Beginning of Effective and Safe Treatment in Immunoglobulin A-1 Nephropathy-1
NCT03357653 ·Status: UNKNOWN ·Phase: PHASE3
-
Mineralocorticoid Antagonism and Endothelial Dysfunction in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
NCT01853553 ·Status: COMPLETED ·Phase: PHASE3
-
Optimalization of Nephroprotection Using Agents Inhibiting Renin-Angiotensin-Aldosterone System
NCT00528385 ·Status: COMPLETED ·Phase: NA
-
Using the Drug Spironolactone to Test If It Reduces Protein Leakage From the Kidney
NCT00106561 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Outcome of ADPKD With Octreotide LAR
NCT06193616 ·Status: ACTIVE_NOT_RECRUITING
-
Pilot Study of Enalapril and Renal Function in Patients With IgA Nephropathy
NCT00006137 ·Status: COMPLETED ·Phase: NA
-
Atorvastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease
NCT05870007 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2